Addendum: de Leve, S.; et al. The CD73/Ado System—A New Player in RT Induced Adverse Late Effects. Cancers 2019, 11, 1578
References
- De Leve, S.; Wirsdorfer, F.; Jendrossek, V. The CD73/Ado System—A New Player in RT Induced Adverse Late Effects. Cancers 2019, 11, 1578. [Google Scholar] [CrossRef] [PubMed]
- Salmi, M.; Jalkanen, S. Cell-surface enzymes in control of leukocyte trafficking. Nat. Rev. Immunol. 2005, 5, 760–771. [Google Scholar] [CrossRef] [PubMed]
- Cappuccini, F. Radiation-induced pneumonitis and fibrosis—Defining the role of immune cells and regulatory molecules. Ph.D. Thesis, University Duisburg-Essen, Essen, Germany, 2017. [Google Scholar]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
de Leve, S.; Wirsdörfer, F.; Jendrossek, V. Addendum: de Leve, S.; et al. The CD73/Ado System—A New Player in RT Induced Adverse Late Effects. Cancers 2019, 11, 1578. Cancers 2019, 11, 1898. https://doi.org/10.3390/cancers11121898
de Leve S, Wirsdörfer F, Jendrossek V. Addendum: de Leve, S.; et al. The CD73/Ado System—A New Player in RT Induced Adverse Late Effects. Cancers 2019, 11, 1578. Cancers. 2019; 11(12):1898. https://doi.org/10.3390/cancers11121898
Chicago/Turabian Stylede Leve, Simone, Florian Wirsdörfer, and Verena Jendrossek. 2019. "Addendum: de Leve, S.; et al. The CD73/Ado System—A New Player in RT Induced Adverse Late Effects. Cancers 2019, 11, 1578" Cancers 11, no. 12: 1898. https://doi.org/10.3390/cancers11121898